K2 Principal Fund, L.P. Nevro Corp Call Options Transaction History

K2 Principal Fund, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $241,060 - $379,270	17,000 New	17,000 $365,000
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $1.14 Million - $1.99 Million	-50,600 Reduced 49.8%	51,000 $1.3 Million
Q1 2023 May 11, 2023	BUY	$30.17 - $41.11 $1.92 Million - $2.61 Million	63,600 Added 167.37%	101,600 $3.67 Million
Q4 2022 Feb 10, 2023	BUY	$36.43 - $49.4 $947,180 - $1.28 Million	26,000 Added 216.67%	38,000 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $487,919 - $636,360	12,000 New	12,000 $559,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $162M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.